35 studies found for:    " June 27, 2012":" July 27, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Atazavanir/Ritonavir-based HAART in Children
Condition: HIV
Intervention: Drug: boosted atazanavir (ATV/r)
22 Active, not recruiting MARCH Central Nervous System Substudy
Condition: HIV-1 Infection
Interventions: Drug: Arm 1 TNucleotide Analogue Reverse Transcriptase Inhibitors and Boosted Protease Inhibitors;   Drug: Arm 2 Maraviroc and Protease Inhibitors;   Drug: Arm 3 Maraviroc and Nucleotide Analogue Reverse Transcriptase Inhibitors
23 Completed Human Immunodeficiency Virus (HIV)and Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: COPD prevalence
24 Active, not recruiting Children With HIV and Asthma (CHIVAS)
Condition: T Cell Response to Asthma in HIV-infected Patients Before and After Starting Treatment
Intervention: Drug: HAART
25 Completed Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine
Condition: HIV
Interventions: Drug: Tenofovir (TFV) Alone Vaginal Tablet;   Drug: Emtricitabine (FTC) Alone Vaginal Tablet;   Drug: TFV and FTC Combined Vaginal Tablet;   Drug: Placebo Vaginal Tablet
26 Completed Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth
Conditions: HIV;   Pregnancy;   Malnutrition;   Cachexia
Intervention:
27 Completed Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Conditions: Opioid Dependence;   Hepatitis;   HIV
Interventions: Other: computerized Cognitive Behavioral Therapy (CBT);   Other: Treatment as Usual (TAU)
28 Recruiting Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
Conditions: Tuberculosis;   HIV
Interventions: Drug: 8 hourly LPV/r during TB treatment;   Drug: Nevirapine;   Drug: Lopinavir/Ritonavir
29 Completed Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics
Condition: HIV Infections
Intervention: Drug: FTC 200 mg/TDF 300 mg fixed-dose combination tablet
30 Completed Violence and HIV Risk Among Women
Condition: HIV Risk Reduction
Interventions: Behavioral: supporting positive and healthy relationships;   Behavioral: community support group
31 Recruiting A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
Condition: HIV-1 Infection
Interventions: Drug: Darunavir;   Drug: Etravirine;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Second line ART regimens are usually based on a boosted protease inhibitor (bPI) plus two nucleoside analogues (NRTIs);   Drug: Study provided drugs according to patient resistance profile (DRV, ETR, RTV, FTC/TDF) + any in country available drug as applicable & available;   Other: SOC adherence versus SOC+CPI adherence
32 Recruiting Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
Conditions: HIV-1 Infection;   Pf Subclinical Parasitemia
Interventions: Drug: Lopinavir/ritonavir;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Efavirenz;   Drug: Nevirapine;   Drug: emtricitabine/tenofovir disoproxil fumarate;   Drug: trimethoprim/sulfamethoxazole
33 Unknown  MyLife MyStyle Evaluation Project
Condition: Unsafe Sex
Intervention: Behavioral: MyLife MyStyle group-level intervention
34 Active, not recruiting Meaning of Life in HIV-infected Youths
Condition: Meaning of Life
Intervention: Behavioral: logotherapy
35 Completed Biomarkers to Detect Anal Intraepithelial Neoplasia in Thai Men Who Have Sex With Men
Condition: Anal Intraepithelial Neoplasia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years